Anthony Dyer

Love Hemp Group Plc operates as an investment vehicle, which identifies investment opportunities and acquisitions in companies. Its investment strategy is to focus on making investments and to acquire companies operating within the burgeoning legal medicinal cannabis, hemp and cannabidiol industries. The company was founded by David Alexander Stadnyk on January 30, 2019 and is headquartered in London, the United Kingdom.

Microgen Bioproducts Ltd. develops, manufactures, distributes, and markets clinical laboratory products. It offers biochemical identification and latex agglutination kits, path-check hygiene and pregnancy tests, pulsifier, and bacterial typing antisera. The company was founded in 1994 and is headquartered in Camberley, the United Kingdom.

Love Hemp Group Plc operates as an investment vehicle, which identifies investment opportunities and acquisitions in companies. Its investment strategy is to focus on making investments and to acquire companies operating within the burgeoning legal medicinal cannabis, hemp and cannabidiol industries. The company was founded by David Alexander Stadnyk on January 30, 2019 and is headquartered in London, the United Kingdom.

Microgen Bioproducts Ltd. develops, manufactures, distributes, and markets clinical laboratory products. It offers biochemical identification and latex agglutination kits, path-check hygiene and pregnancy tests, pulsifier, and bacterial typing antisera. The company was founded in 1994 and is headquartered in Camberley, the United Kingdom.

Love Hemp Group Plc operates as an investment vehicle, which identifies investment opportunities and acquisitions in companies. Its investment strategy is to focus on making investments and to acquire companies operating within the burgeoning legal medicinal cannabis, hemp and cannabidiol industries. The company was founded by David Alexander Stadnyk on January 30, 2019 and is headquartered in London, the United Kingdom.

Love Hemp Group Plc operates as an investment vehicle, which identifies investment opportunities and acquisitions in companies. Its investment strategy is to focus on making investments and to acquire companies operating within the burgeoning legal medicinal cannabis, hemp and cannabidiol industries. The company was founded by David Alexander Stadnyk on January 30, 2019 and is headquartered in London, the United Kingdom.